BioCentury
ARTICLE | Financial News

Galmed raises $75M follow-on

June 20, 2018 6:45 PM UTC

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) raised $75 million through the sale of 5 million shares at $15 in a follow-on underwritten by Stifel, SunTrust Robinson Humphrey, Cantor Fitzgerald, Raymond James, Roth Capital Partners, Maxim Group and Seaport Global Securities.

The price is a tiny premium to Galmed's close of $14.91 on Monday, when it proposed after market hours to raise $75 million...

BCIQ Company Profiles

Galmed Pharmaceuticals Ltd.